Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B D Vallance
Fenofibrate Reduces Low Density Lipoprotein Catabolism in Hypertriglyceridemic Subjects
Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
Related publications
Glucosyl Hesperidin Lowers Serum Triglyceride Level in Hypertriglyceridemic Subjects Through the Improvement of Very Low-Density Lipoprotein Metabolic Abnormality
Journal of Nutritional Science and Vitaminology
Medicine
Nutrition
Dietetics
Low Density Lipoprotein Causes General Cellular Activation With Increased Phosphatidylinositol Turnover and Lipoprotein Catabolism.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Glycation of Very Low Density Lipoprotein From Rat Plasma Impairs Its Catabolism
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Fenofibrate Modifies Human Vascular Smooth Muscle Proteoglycans and Reduces Lipoprotein Binding
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Catabolism of Very Low Density Lipoprotein; Especially Change of Interaction of Lipoproteins on Heparin Infusion
The Journal of Japan Atherosclerosis Society
A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Low-Density Lipoprotein Receptor (LDLR)
Science-Business eXchange
Low-Density Lipoprotein Receptor (LDLR)
Science-Business eXchange
The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
